ProteoNic announces collaboration with TNO
"The use of the UNic(tm) expression enhancement technology has helped us tremendously to increase the efficiency of our protein production and has resulted in substantial cost reductions." TNO senior investigator Jan Verheijen commented. "One particular advantage was that downstream processing could remain unaltered, enabling a smooth introduction of the optimized process. The UNic(tm) technology combined with TNO's proprietary QuickZyme technology platform will give a boost to the development and manufacturing of novel protease activity assays."
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.